by AJWRB Staff | Sep 25, 2026 | Institutional Policy & Watchtower Reform, Bioethics & Medical Ethics, Clinical Guidance & Practice, Medico-Legal Liability & Informed Consent, Patient Management
Written for current Jehovah’s Witnesses, this statement explains the 2026 blood policy changes and supports informed medical choice. Clinicians can share it with patients, and family members with Witness relatives.
by AJWRB Staff | Sep 25, 2026 | Bioethics & Medical Ethics, Clinical Guidance & Practice, Historical Policy Evolution, Institutional Policy & Watchtower Reform, Medico-Legal Liability & Informed Consent, Patient Management, Uncategorized
AJWRB responds to the 2026 Jehovah’s Witness blood-policy reforms, examining conscience, whole blood, informed consent, accountability, and unresolved harms.
by Lee Elder, Executive Director - AJWRB | Sep 18, 2026 | Clinical Guidance & Practice, Historical Policy Evolution, Institutional Policy & Watchtower Reform, Medico-Legal Liability & Informed Consent
Originally published September 18, 2026 |Last updated September 19, 2026 The Jehovah’s Witness blood policy changed substantially on September 18, 2026. In Governing Body Update #6 and an accompanying “Questions From Readers” article, Jehovah’s Witness leadership...
by Lee Elder, Executive Director - AJWRB | Aug 9, 2026 | Bioethics & Medical Ethics, Historical Policy Evolution, Institutional Policy & Watchtower Reform, Medico-Legal Liability & Informed Consent
Published March 22, 2026 | Last Updated September 20, 2026 Progress, Accountability, and the Future of Blood Policy Jehovah’s Witness Blood Policy 2026: What Changed? On March 20, 2026, Jehovah’s Witnesses changed their policy regarding the medical use of a...
by Lee Elder, Executive Director - AJWRB | Jul 23, 2026 | Bioethics & Medical Ethics, Hematology & Biomedical Science, JW Crisis Management, Medico-Legal Liability & Informed Consent
2026 Retrospective Note: The epidemiological projections established in this 2017 paper remain an important framework to tracking historical policy impacts. Notably, the March 2026 reclassification of preoperative autologous blood donation (PAD) to a matter of...
by Lee Elder, Executive Director - AJWRB | Jul 5, 2026 | Institutional Policy & Watchtower Reform, JW Crisis Management, Medico-Legal Liability & Informed Consent, Pediatric Bioethics & Minor Rights
Introduction The refusal of blood transfusions by Jehovah’s Witnesses is widely recognized within medical ethics as an expression of religious conscience and patient autonomy. However, when clinicians are evaluating Jehovah’s Witness informed consent, the...
Recent Comments